LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹481 Cr | ₹421 Cr | ₹377 Cr | ₹337 Cr | ₹321 Cr |
What is the latest Total Expenditure of LINCOLN PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹481 Cr |
| Mar2024 | ₹421 Cr |
| Mar2023 | ₹377 Cr |
| Mar2022 | ₹337 Cr |
| Mar2021 | ₹321 Cr |
How is Total Expenditure of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹481 Cr | 14.14 | |
| Mar2024 | ₹421 Cr | 11.81 | |
| Mar2023 | ₹377 Cr | 11.76 | |
| Mar2022 | ₹337 Cr | 5.00 | |
| Mar2021 | ₹321 Cr | - | |
Compare Total Expenditure of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,215.2 Cr | -1.9% | 4.9% | 13.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -1.9% |
4.9% |
13.2% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses